“Mesotherapy”的搜索结果，显示 371-380 项，共有 10250 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The present study is an open-label, randomized, controlled, two-arm multi-center study of the efficacy of L19TNF treatment in combination with doxorubicin ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Scottsdale/Phoenix, Ariz. This phase I/II trial studies the side effects and best dose of romidepsin and lenalidomide when combined with ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab rilsodotin) in ...

7. 临床试验 - 胃肠病科和肝病科

   Difference in postprandial GV and in accommodation volume (that is, postprandial minus fasting gastric volumes);; Difference in gastric emptying (T1/2, emptying ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy. ( ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 6 months of documentation of HLA-A LOH status. The percentage ...

10. 血液科- 临床试验- 妙佑医疗国际

    This is a peripheral blood Collection Protocol to study the T-cell immune responses of patients with malignancies displaying one of three different patterns ...